Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that with the right reforms, expanding drug-price negotiations can lower costs without impeding innovation.
Related Posts
Every Artist With 100 or More Billboard Hot 100 Chart Hits
Debuting a song on the Billboard Hot 100 is a highlight of any musician’s career. It’s Billboard’s premier songs chart…
“Family Guy” creator Seth MacFarlane on his other love: Sinatra
The writer-producer-voice artist behind the animated hit is also a crooner of the Great American Songbook. He is now releasing…
Copying India, Pakistan Announces Its Own Diplomatic Outreach Programme
In yet another move imitating India’s actions, Pakistan Prime Minister Shehbaz Sharif has asked former Foreign Minister Bilawal Bhutto-Zardari to…